#ES­MO20: Bris­tol My­ers marks Op­di­vo's sec­ond ad­ju­vant win — eye­ing a stan­dard of care gap

Mov­ing in­to ear­li­er and ear­li­er treat­ment lines, Bris­tol My­ers Squibb is re­port­ing that ad­ju­vant treat­ment with Op­di­vo has dou­bled the time that esophageal or gas­troe­sophageal …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER